Promega Corporation

180 articles about Promega Corporation

• Promega Named a BioSpace 2024 Best Places to Work Winner

  11/8/2023

  Promega Corporation has been named a BioSpace 2024 Best Place to Work.

• Cell-Based Assays Reveal Two Reported Anti-Inflammation Molecules Fail to Engage Target Protein

  10/25/2023

  A new study uses key Promega technologies to evaluate reported anti-inflammation molecules in the context of live cells.

• Promega to Develop Microsatellite Instability (MSI) Companion Diagnostic IVD Kit in Collaboration With GSK

  10/3/2023

  Promega Corporation today announced it plans to develop and commercialize a microsatellite instability (MSI) companion diagnostic (CDx) IVD kit with GSK to identify adult cancer patients with MSI-H solid tumors who may be eligible for potential treatment with GSK’s Jemperli (dostarlimab-gxly).

• INOVIQ and Promega Announce Global Joint Marketing Agreement for EXO-NET Exosome Isolation and Nucleic Acid Purification Solutions

  7/6/2023

  INOVIQ and Promega sign a global joint marketing agreement for INOVIQ’s EXO-NET® exosome capture technology and Promega Nucleic Acid purification systems.

• New Promega Chemistry Will Enable Forensic DNA Labs to Solve More Challenging Cold Cases, Sexual Assault Cases

  1/31/2023

  New chemistry for DNA analysis will empower forensic laboratories to overcome common challenges including degraded and contaminated samples.

• Forensic Laboratories Gain Unique Flexibility with Spectrum CE System

  5/17/2022

  Forensics laboratories performing human identification in criminal casework and database cases have a new option for a capillary electrophoresis (CE) instrument to support their workflow.

• Researchers Studying Inflammation Can Simplify Cytokine Detection with New Promega Lumit Immunoassays

  3/30/2022

  Researchers studying immunity and inflammation now have a faster, easier alternative to traditional enzyme-linked immunosorbent assays (ELISAs) with new Promega bioluminescent assays launched today.

• Promega to Launch Post-Doctoral Research Program to Develop New Tools for Genome Editing

  3/29/2022

  Life science researchers can explore new ideas for genome engineering technology through a newly announced post-doctoral research program launched by Promega with mentoring support from AstraZeneca.

• New Study Validates Novel Markers for Detecting Microsatellite Instability in Multiple Cancers

  2/3/2022

  Researchers from Johns Hopkins University have shown that a new panel of long mononucleotide repeats (LMR) might offer advantages over traditional microsatellite instability (MSI) detection methods in certain types of solid tumors.

• Promega Launches Sanger Sequencing Chemistry Compatible With All Capillary Electrophoresis Platforms

  10/19/2021

  Research labs performing Sanger sequencing can now use Promega chemistry on any capillary electrophoresis (CE) platform.

• Applications of Bioluminescent Research Tools Showcased at Global Seminar Series

  8/24/2021

  Life science and drug discovery researchers interested in bioluminescent tools will have the opportunity to hear from global thought leaders on the possibilities and applications of luciferase technologies during the upcoming Discover Glo 2021 virtual seminar series.

• Wastewater Testing Labs Can Detect SARS-CoV-2 in Less Than Four Hours with New Methods

  8/16/2021

  A complete workflow developed by Promega Corporation enables wastewater testing laboratories, including public health organizations, to quickly assess the health of entire communities from a single sample.

• Promega 2021 Corporate Responsibility Report Sets 2030 Sustainability Targets, Spotlights COVID-19 Response

  6/23/2021

  Promega Corporation. The 2021 Corporate Responsibility Report, released today, features new 2030 Environmental Improvement Goals alongside stories of how Promega is supporting researchers, employees and communities during the COVID-19 pandemic.

• Biotech and Pharma Labs Performing Endpoint PCR Can Reduce Amplification Time to 15 Minutes With New Promega Reagent and Eppendorf Instrument Combination

  6/8/2021

  Promega GoTaq® Rapid Master Mix paired with Eppendorf Mastercycler® X50s thermal cycler is one of the fastest endpoint PCR solutions available

• Promega, Exact Sciences Partnering to Help Jumpstart Colorectal Cancer Screenings

  5/10/2021

  Serious runners and casual walkers alike are invited to join a month-long Get Your Rear in Gear® - Madison run/walk virtual event during May to raise money and awareness for colorectal cancer screening efforts.

• Promega Opens New Research & Development Facility Supporting Science at the Edge of Innovation

  4/6/2021

  Promega Corporation announced the opening of Kornberg Center, the biotech company’s newly constructed research and development facility on its Fitchburg, WI campus.

• Consciousness of Connection – Awakening from Despair to Awe: 2021 International Forum on Consciousness to Explore Connections That Support Mutual Flourishing

  3/31/2021

  General public invited to join thought leaders in psychiatry, business, neurobiology May 20-21 for virtual conversations on connections that transcend and transform

• Cancer Researchers Can Assess Microsatellite Instability (MSI) Through New Lens with Expanded Promega System

  2/17/2021

  A new microsatellite instability (MSI) system launched today by Promega Corporation enables cancer researchers to evaluate a new set of unique MSI markers that may offer additional precision in the characterization of their tumor samples.

• Promega Surpasses Environmental Improvement Goals and Achieves Absolute Reductions

  7/29/2020

  Promega Corporation has surpassed all its environmental improvement goals set for the end of 2020, and achieved absolute reductions in key sustainability metrics, according to the company’s newly released Corporate Responsibility Report. The annual report details the global biotech manufacturer’s outcomes fr

• Promega Maxwell RNA Extraction System Authorized for Use in CDC COVID-19 Emergency Use Authorization (EUA) Diagnostic Panel

  7/16/2020

  Promega Corporation’s Maxwell ® RSC 48 Instrument and Maxwell ® RSC Viral Total Nucleic Acid Purification Kit (Maxwell Extraction System) are now in the Centers for Disease Control and Prevention’s (CDC) COVID-19 diagnostic protocol for emergency use. In a letter dated July 13, 2020, the U.S. Food and Drug Administration (FDA) auth